Graeme Martin Brown
Corporate Officer/Principal at University of London
Profile
Graeme Martin Brown is the founder of Vaxome Ltd.
and Activiomics Ltd.
He currently works as the Director of Technology Transfer at the University of London.
He holds a doctorate degree from the University of Cambridge.
Graeme Martin Brown active positions
| Companies | Position | Start |
|---|---|---|
| University of London | Corporate Officer/Principal | 31/12/2001 |
Former positions of Graeme Martin Brown
| Companies | Position | End |
|---|---|---|
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Founder | 15/03/2011 |
Vaxome Ltd.
 Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Founder | - |
Training of Graeme Martin Brown
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Vaxome Ltd.
Vaxome Ltd. Pharmaceuticals: MajorHealth Technology Vaxome Ltd. developed vaccine delivery technology. The firm offered a novel vaccine delivery technology for antigen presentation and delivery system for stimulating T cell-mediated immune responses. The company was founded by Ping Wang in 2004 and was headquartered in London, the United Kingdom. | Health Technology |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Graeme Martin Brown
